Federal authorities have told the Southern California maker of Botox, the hugely popular antiwrinkle drug, that its ads are misleading and minimize the treatment's risks. The Food and Drug ...

There are a few wrinkles to Botox ads that frowning federal regulators want removed. The U.S. Food and Drug Administration contends that TV and print ads for the popular anti-aging elixir are ...

Print and television ads for the wrinkle-smoothing drug Botox are misleading and should be pulled until they are changed, the U.S. Food and Drug Administration told the drug's maker Allergan Inc.

LOS ANGELES – Print and television ads for the wrinkle-smoothing drug Botox are misleading and should be pulled until they are changed, the U.S. Food and Drug Administration told the drug's maker ...

For the second time in less than a year, the Food and Drug Administration has warned Irvine-based Allergan Inc. that advertisements for its anti-wrinkle drug Botox are misleading and should be pulled.

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Ads for Botox Cosmetic may contain “misleading statements,” according to a notice of violation sent ...

The Food and Drug Administration has demanded that Allergan Inc. “immediately cease distribution” of television advertisements and patient brochures for Botox Cosmetic, charging that they violate ...